InvestorsHub Logo
Followers 43
Posts 10679
Boards Moderated 0
Alias Born 07/15/2007

Re: JG36 post# 64531

Friday, 12/28/2012 3:16:03 PM

Friday, December 28, 2012 3:16:03 PM

Post# of 146242
JG36

You need to add up the FDA meetings and the progress of FLUCIDE, IV FLUCIDE, and ORAL FLUCIDE,and the potential of an ORPHAN DESIGNATION for immuno compromised patients FLUCIDE.

Those are something.

The burn rate is calculated with the intended actions in there.



Echo20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News